CuraScientific (CSTF) Ratios
CuraScientific Ratios
CSTF's free cash flow for Q3 2023 was $-352.62K. For the 2023 fiscal year, CSTF's free cash flow was decreased by $-97.69K and operating cash flow was $-254.93K. See a summary of the company’s cash flow.
| Ratios | Dec 22 | Dec 21 | Dec 20 | Dec 19 | Dec 18 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 |
| Quick Ratio | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 |
| Cash Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Solvency Ratio | -0.07 | -0.07 | -0.02 | 0.00 | 0.09 |
| Operating Cash Flow Ratio | -0.00 | -0.01 | -0.00 | 0.00 | 0.00 |
| Short-Term Operating Cash Flow Coverage | -0.10 | -0.52 | -0.99 | 0.01 | 0.00 |
| Net Current Asset Value | $ -71.02M | $ -71.50M | $ -199.42M | $ -394.52K | $ -111.96K |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 1.70 | 0.47 | 0.16 | 1.02 | 0.97 |
| Debt-to-Equity Ratio | -0.04 | -0.02 | -0.00 | -41.86 | 28.74 |
| Debt-to-Capital Ratio | -0.04 | -0.02 | -0.00 | 1.02 | 0.97 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 1.02 | 0.97 |
| Financial Leverage Ratio | -0.02 | -0.03 | -0.01 | -40.86 | 29.74 |
| Debt Service Coverage Ratio | -0.89 | -1.85 | -5.09 | 0.10 | 1.87 |
| Interest Coverage Ratio | -1.95 | -4.13 | -6.87 | 0.21 | 0.93 |
| Debt to Market Cap | 0.06 | 0.02 | 0.00 | 0.07 | 0.00 |
| Interest Debt Per Share | 0.82 | 7.29 | 13.69 | 672.04 | 209.22 |
| Net Debt to EBITDA | -0.77 | -0.25 | -0.11 | 28.49 | 5.12 |
| Profitability Margins | |||||
| Gross Profit Margin | -3298.12% | 64.12% | 69.35% | 67.45% | 65.91% |
| EBIT Margin | -11759.33% | -5463.62% | -7472.98% | 3.57% | 12.70% |
| EBITDA Margin | -9969.64% | -4754.88% | -6831.33% | 17.07% | 25.55% |
| Operating Profit Margin | -6910.85% | -5537.09% | -4210.35% | 3.57% | 12.70% |
| Pretax Profit Margin | -15299.16% | -6805.12% | -8085.52% | -13.09% | -0.93% |
| Net Profit Margin | -15299.16% | -6805.12% | -8085.52% | -13.09% | -0.93% |
| Continuous Operations Profit Margin | -15299.16% | -6805.12% | -8085.52% | -13.09% | -0.93% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 221.38% | 122.90% | 192.04% | -366.46% | -7.32% |
| Return on Assets (ROA) | -339.49% | -262.01% | -177.96% | -2.74% | -0.66% |
| Return on Equity (ROE) | 7.58% | 8.46% | 2.47% | 111.97% | -19.72% |
| Return on Capital Employed (ROCE) | 3.44% | 6.88% | 1.29% | -1.57% | 9.06% |
| Return on Invested Capital (ROIC) | 3.57% | 6.99% | 1.29% | -4.50% | 9.06% |
| Return on Tangible Assets | -4155.16% | -2725.58% | -4495.01% | -2.74% | -0.66% |
| Earnings Yield | -11.15% | -9.20% | -1.22% | -0.14% | -0.00% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 5.17 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 3.54 | 0.27 | 0.14 | 0.00 | 0.00 |
| Inventory Turnover | 0.00 | 3.68 | 2.68 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.40 | 0.98 | 0.64 | 0.78 | 0.74 |
| Asset Turnover | 0.02 | 0.04 | 0.02 | 0.21 | 0.71 |
| Working Capital Turnover Ratio | -0.00 | -0.00 | -0.00 | -0.29 | 3.12 |
| Cash Conversion Cycle | -103.09 | -1166.57 | -2565.21 | 0.00 | 0.00 |
| Days of Sales Outstanding | 0.00 | 70.64 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 99.11 | 136.35 | 0.00 | 0.00 |
| Days of Payables Outstanding | 103.09 | 1336.32 | 2701.57 | 0.00 | 0.00 |
| Operating Cycle | 0.00 | 169.75 | 136.35 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.05 | -1.82 | -7.34 | 2.12 | 19.18 |
| Free Cash Flow Per Share | -0.06 | -1.84 | -7.34 | 2.12 | 19.18 |
| Dividend Paid and CapEx Coverage Ratio | -17.01 | -98.64 | 0.00 | 0.33 | 0.79 |
| Capital Expenditure Coverage Ratio | -17.01 | -98.64 | 0.00 | 0.00 | 0.00 |
| Operating Cash Flow Coverage Ratio | -0.10 | -0.52 | -0.99 | 0.00 | 0.10 |
| Operating Cash Flow to Sales Ratio | -7.37 | -6.42 | -7.20 | 0.02 | 0.14 |
| Free Cash Flow Yield | -0.57% | -0.88% | -0.11% | 0.02% | 0.04% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -8.97 | -10.87 | -81.85 | -717.24 | -41397.19 |
| Price-to-Sales (P/S) Ratio | 1372.34 | 739.82 | 6617.66 | 93.90 | 384.72 |
| Price-to-Book (P/B) Ratio | -0.68 | -0.92 | -2.02 | -803.09 | 8164.56 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -175.92 | -114.08 | -918.57 | 5892.62 | 2815.46 |
| Price-to-Operating Cash Flow Ratio | -186.26 | -115.24 | -918.57 | 5892.62 | 2815.46 |
| Price-to-Earnings Growth (PEG) Ratio | 0.10 | 0.14 | -0.22 | -0.58 | 401.42 |
| Enterprise Value Multiple | -14.53 | -15.81 | -96.98 | 578.51 | 1511.16 |
| Enterprise Value | 49.89M | 64.85M | 398.53M | 8.04M | 33.06M |
| EV to EBITDA | -14.53 | -15.81 | -96.98 | 578.51 | 1511.16 |
| EV to Sales | 1448.92 | 751.83 | 6624.84 | 98.76 | 386.03 |
| EV to Free Cash Flow | -185.73 | -115.93 | -919.57 | 6197.86 | 2825.03 |
| EV to Operating Cash Flow | -196.65 | -117.11 | -919.57 | 6197.86 | 2825.03 |
| Tangible Book Value Per Share | -15.01 | -234.99 | -3376.67 | -15.53 | 6.61 |
| Shareholders’ Equity Per Share | -14.71 | -228.33 | -3332.20 | -15.53 | 6.61 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.01 | 0.28 | 1.02 | 132.80 | 140.36 |
| Net Income Per Share | -1.11 | -19.32 | -82.40 | -17.39 | -1.30 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.30 | 1.25 | 1.08 | -3.67 | -0.07 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 51.85 | 48.92 | 36.38 | 0.90 | 0.00 |
| Stock-Based Compensation to Revenue | 13.79 | 38.29 | 26.60 | 0.00 | 0.00 |
| Income Quality | 0.05 | 0.09 | 0.09 | -0.12 | -14.70 |
Currency in USD